Polyclonal Rabbit anti‑Human ADSL / Adenylosuccinate Lyase Antibody (aa1‑310, IHC, WB) LS‑C375160
Polyclonal Rabbit anti‑Human ADSL / Adenylosuccinate Lyase Antibody (aa1‑310, IHC, WB) LS‑C375160
Antibody:
ADSL / Adenylosuccinate Lyase Rabbit anti-Human Polyclonal (aa1-310) Antibody
Application:
IHC, IHC-P, WB, ELISA
Format:
Unconjugated, Unmodified
Overview
Antibody:
ADSL / Adenylosuccinate Lyase Rabbit anti-Human Polyclonal (aa1-310) Antibody
Application:
IHC, IHC-P, WB, ELISA
Format:
Unconjugated, Unmodified
Specifications
Description
Adenylosuccinate Lyase antibody LS-C375160 is an unconjugated rabbit polyclonal antibody to Adenylosuccinate Lyase (ADSL) (aa1-310) from human. It is reactive with human and mouse. Validated for ELISA, IHC and WB.
Target
Human ADSL / Adenylosuccinate Lyase
Synonyms
ADSL | Adenylosuccinate lyase | AMPS | ASASE | Adenylosuccinase
Reactivity
Human, Mouse
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Immunoaffinity purified
Immunogen
Recombinant human Adenylosuccinate lyase protein (aa1-310).
Specificity
Human ADSL / Adenylosuccinate Lyase
Applications
- IHC
- IHC - Paraffin (1:20 - 1:200)
- Western blot (1:500 - 1:2000)
- ELISA
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Presentation
PBS, pH 7.3, 0.02% Sodium Azide, 50% Glycerol
Storage
Short term: -20°C; Long term: -80°C; Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About ADSL / Adenylosuccinate Lyase
Featured Products
Species:
Human, Mouse, Rat
Applications:
ICC, Immunofluorescence, Western blot
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 12/24/2024